Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data-Reference-Cited by-同舟云学术

Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data

Published:2019-11-08 Issue:1 Volume:19 Page:107-112
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Vielot Nadja A.¹^ORCID,Becker-Dreps Sylvia¹²^ORCID

Affiliation:

1. Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

2. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1688299

Reference27 articles.

1. World Health Organization. Weekly epidemiological record [Internet]. Geneva, Switzerland; 2017. Available from: http://www.who.int/wer/2017/wer9228/en/.

2. Peripheral Sympathetic Nerve Dysfunction in Adolescent Japanese Girls Following Immunization with the Human Papillomavirus Vaccine

3. Sherry DD Complex regional pain syndrome in children [Internet]. Up to Date. 2019 [cited 2019 Oct 14]. Available from: https://www.uptodate.com/contents/complex-regional-pain-syndrome.

4. An update on complex regional pain syndromes in children and adolescents

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches in Postapproval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature;Clinical Therapeutics;2024-07

2. Post‐COVID ‐19 vaccination arm pain diagnosed as complex regional pain syndrome: A case report;Pain Practice;2022-11-12

3. Correction;Expert Opinion on Drug Safety;2021-04-22